PMGC HOLDINGS INC. Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants
PMGC HOLDINGS INC. (ELAB) had Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants of 14.05 thousand shares as of 2024-09-24, per its 10-K filed 2025-03-28.
Financial Statements › Notes
us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants · last filed 2025-03-28
- 2024-09-24: Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 14.05K shares; Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants as first filed 19.67M shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants as first filed |
|---|---|---|
| 2024-09-24 | 14.05K shares 10-K · filed 2025-03-28 | 19.67M shares 10-Q · filed 2024-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B |